期刊文献+

卵巢甲状腺肿68例临床分析 被引量:12

Clinical study on 68 cases with struma ovarii
原文传递
导出
摘要 目的 探讨卵巢甲状腺肿的临床特点、治疗及预后.方法 回顾性分析中国医学科学院北京协和医院1990年1月至2012年1月间收治的68例卵巢甲状腺肿患者的临床资料.结果 (1)一般情况:68例患者的中位年龄42岁(17 ~81岁);其中良性卵巢甲状腺肿64例(94%),恶性卵巢甲状腺肿4例(6%).(2)临床表现:32例(47%)患者为健康体检时超声检查发现盆腔包块就诊,28例(41%)患者以腹痛就诊,8例(12%)患者自行扪及下腹包块就诊.54例患者术前有血清CA125检查,仅8例(15%)异常.所有患者均行术前超声检查,其中51例(75%)为多房囊性包块,14例(21%)为囊实性包块,3例(4%)为实性包块.肿瘤的平均直径为(8±3)cm.4例(6%)患者术中可见腹水.68例患者中,67例患者病变位于单侧卵巢,仅1例为双侧.术前患者均无甲状腺功能亢进(甲亢)的临床表现,术后有19例患者行甲状腺功能检查,结果均正常.(3)治疗:所有患者均接受手术治疗.64例良性卵巢甲状腺肿患者中,25例行囊肿剔除术,15例行单侧附件切除术,2例行双侧附件切除术,22例行子宫全切除+单侧或双侧附件切除术.4例恶性卵巢甲状腺肿患者中,3例行保留生育功能手术,其中1例行保留生育功能的分期手术、2例行患侧附件切除术,1例行子宫全切除+双侧附件切除术,2例患者术后接受化疗.(4)预后:良性卵巢甲状腺肿患者的中位随访时间为5.4年(6个月~21年),均无复发.4例恶性甲状腺肿患者的中位随访时间为11.5年(9~ 20年),有3例复发,复发时间分别为术后2、7、16年.复发后均接受再次手术治疗,其中2例患者接受甲状腺切除术联合131I治疗;到随访结束时,4例患者均存活.结论 卵巢甲状腺肿是少见的卵巢单胚层畸胎瘤.囊肿剔除或附件切除可能是良性卵巢甲状腺肿适宜的治疗方法,而恶性卵巢甲状腺肿发病率低,缺乏标准的治疗方案.因恶性卵巢甲状腺肿有远期复发风险,需要严密随访. Objective To study the clinical features,treatment and prognosis of struma ovarii.Methods From January 1990 to January 2012,a total of 68 patients were diagnosed struma ovarii at the Department of Obstetrics and Gynecology,Peking Union Medical College Hospital.Clinical data of these patients were studied retrospectively.Results (1) Characteristics of patients:the median age of patients was 42 years old (17-81 years).Of those patients,64 cases (94%) were diagnosed begin struma ovarii and 4(6%) were malignant struma ovarii.(2) Clinical feature:32(47%,32/68) patients were identified with pelvic mass by ultrasonic test,28 cases(41%) had clinical abdominal pain,8(12%) touched a mass from abdominal wall.Preoperative CA125 were tested in 54 patients,but only 8 cases(15%) had moderate elevation.All patients receive ultrasound examination,and 51 cases (75%) were mulitcystic lesions with many septi,3(4%) solid lesions and 14(21%) solid-cystic tumors.The mean diameter of tumors was(8 ± 3) cm.Ascites was present in 4 (6%,4/68)patients.Sixty-seven patients had unilateral lesions,and 1 patient had bilateral lesions.No patient had hyperthyroidism presentation.Nineteen cases underwent thyroid function test after operation,and the results were normal.(3) Treatment:all patients underwent surgical treatment.Among patients with begin struma ovarii,25 cases underwent cystectomy,15 cases unilateral,2 bilateral salpingo-oophorectomy,22 cases hysterectomy + unilateral or bilateral salpingo-oophorectomy.Four malignant struma ovarii,1 patient underwent fertility-sparing staging surgery,2 patients unilateral salpingo-oophorectomy,1 case hysterectomy + bilateral salpingo-oophorectomy.Two patients received chemotherapy after surgery.(4) Prognosis:all patients were followed up in Peking Union Medical College Hospital.The median follow-up time of benign struma ovarii was 5.4 years (6 months-21 years) and there were no recurrence.The median follow-up time of malignant struma ovarii was 11.5 years (9-20 years).Three cases had long-term recurrence at 2,7 and 16 years respectively after surgery.They were received surgical treatment after recurrence and all were alive.Two cases were given by thyroidectomy and 131I treatment.Conclusions Struma ovarii is a rare ovarian monodermal teratoma.Tumorectomy or salpingo-oophorectomy is the appropriate therapeutic treatment for benign struma ovarii.The incidence of malignant struma ovarii is low,and there are no standard treatments.Because of higher long-term recurrence rate,these patients need close follow-up.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2014年第6期451-454,共4页 Chinese Journal of Obstetrics and Gynecology
关键词 卵巢甲状腺肿 畸胎瘤 肿瘤治疗方案 Struma ovarii Teratoma Antineoplastic protocols
  • 相关文献

参考文献14

  • 1Boetdin R. Uber zahnentwickelung in dermoid cysten des ovariums [J] . Virchows Arch Path Arat, 1889,115:493-504.
  • 2Roth LM, Karseladze AI. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis [ J]. Int J Gynecol Pathol,2008 ,27 :213-222.
  • 3Shaco-Levy R, Peng RY, Snyder M J, et al. Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior [ J ]. Arch Pathol Lab Med ,2012,136 : 172-178.
  • 4Hatami M, Breining D, Owers RL, et al. Malignant struma ovarii-a case report and review of the literature [ J ]. Gynecol Obstet Invest ,2008,65 : 104-107.
  • 5Yoo SC, Chang KH, Lyu MO, et al. Clinical characteristics of struma ovarii[J]. J Gyneeol 0ncol,2008,19:135-138.
  • 6Oueslati H, Mezghenni S, Hsayoui N, et al. Struma ovarii : clinical presentations of an uncommon tumor [ J ] . Inter J Case Report Images, 2012,3 : 10.
  • 7Ikeuchi T, Koyama T, Tamai K, et al. CT and MR features of struma ovarii[J]. Ahdom Imaging,2012,37:904-910.
  • 8Kraemer B, Grischke EM, Staebler A, et al. Laparoscopic excision of malignant struma ovarii and 1 year follow-up without further treatment[J]. Fertil Steril,2011,95 :2124-2129.
  • 9Robboy SJ, Shaco-Levy R, Peng RY, et al. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread[J]. Int J Gynecol Pathol,2009,28:405-422.
  • 10刘爱军,张廷国,王美清.卵巢甲状腺肿临床病理学分析[J].现代妇产科进展,2008,17(1):36-39. 被引量:13

二级参考文献9

  • 1Roth LM, Talerman A. Recent advances in pathology and classification of ovarian germ cell tumors [ J ]. Int J Gynecol Pathol,2006,25 : 305-320
  • 2DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii:a case report and analysis of cases reported in the literature with focus on survival and ^131Ⅰ therapy [ J ]. Gynecol Oncol,2003,89 : 543 -548
  • 3Tavassoli FA, Devilee P. World health orgnization classification of tumours. Pathology and Genetics, tumors of the breast and female genital organs [ M ]. Lyon: IARC Press, 2003 : 163-175
  • 4Huh J J, Montz FJ, Bristow RE. Struma ovarii associated with pseudo-Meigs′ syndrome and elevated serum CA125 [ J ]. Gynecol Oncol,2002,86:231-234
  • 5Loizzi V, Cormio G, Resta L, et al. Pseudo-Meigs syndrome and elevated CA125 associated with struma ovarii[J ]. Gynecol Oncol,2005,97:282-284
  • 6Teale E, Gouldesbrough DR, Peacey SR. Graves′ disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyretropin receptor stimulating antibodies [ J ]. Thyroid,2006,16:791-793
  • 7Kabukcuoglu F, Baksu A, Yilmaz B, et al. Malignant struma ovarii [ J ]. Pathol Oncol Res,2002,8 : 145-147
  • 8Bolat F, Erkanli S, Kayaselcuk F, et al. Malignant stmma ovarii : a case report [ J ]. Pathol Res Pract, 2005,201 : 409-412
  • 9刘爱军,宫庭钰,李亚里,宋晶莹,刘翠云,韦立新,陈乐真.卵巢原发性类癌7例临床病理分析[J].诊断病理学杂志,2007,14(6):411-414. 被引量:9

共引文献12

同被引文献49

  • 1何春年,徐翠清,陈琛,石卫东,霍俊爱,翟金萍.卵巢恶性甲状腺肿2例并文献复习[J].临床与实验病理学杂志,2005,21(3):314-317. 被引量:9
  • 2陈定宝,沈丹华,季福水,潘虹.卵巢甲状腺肿临床病理学探讨[J].中国妇产科临床杂志,2005,6(4):259-261. 被引量:6
  • 3王艳艳,尹福波,焦琦琦.卵巢甲状腺肿2例并文献复习[J].现代妇产科进展,2006,15(1):72-73. 被引量:7
  • 4Roth LM,Karseladze AI.Highly differentiated follicular carcinoma arising from struma ovarii:a report of 3 cases,a review of the literature,and a reassessment of so-called peritoneal strumosis[J].Int J Gynecol Pathol,2008,27(2):213-222.
  • 5Kondo T,Ezzat S,Asa SL.Pathogenetic mechanisms in thyroid follicular-cell neoplasia[J].Nature Reviews Cancer,2006,6(4):292-306.
  • 6Schmidt J,Derr V,Heinrich MC,et al.BRAF in papillary thyroid carcinoma of ovary(struma ovarii)[J].Am J Surg Pathol,2007,31(9):1337-1343.
  • 7Flavin R,Smyth P,Crotty P,et al.BRAF T1799A mutation occurring in a case of malignant struma ovarii[J].Int J Surg Pathol,2007,15(2):116-120.
  • 8Celestino R,Magalh?es J,Castro P,et al.A follicular variant of papillary thyroid carcinoma in struma ovarii.Case report with unique molecular alterations[J].Histopathology,2009,55(4):482-487.
  • 9Coyne C,Nikiforov YE.RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii[J].Endocrine Pathology,2010,21(2):144-147.
  • 10Boutross-Tadross O,Saleh R,Asa SL.Follicular variant papillary thyroid carcinoma arising in struma ovarii[J].Endocrine Pathology,2007,18(3):182-186.

引证文献12

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部